Rosuvastatin Tablet, Film Coated
Product Images NDC 71335-2440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71335-2440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence line chart comparing Rosuvastatin (solid line) and placebo (dotted line) over approximately 5 years. The graph shows lower cumulative incidence percentages for Rosuvastatin with a hazard ratio (HR) of 0.56 (95% CI 0.46-0.69) and a significance of P<0.001. Below the graph, the number of subjects at risk is displayed for each group across time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A table comparing clinical trial event rates between Rosuvastatin 20 mg and placebo 20 mg groups for various cardiovascular endpoints. Columns show event numbers, hazard ratios with 95% confidence intervals, and p-values. A forest plot graphically displays hazard ratios and confidence intervals for primary and secondary cardiovascular outcomes.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box plot chart comparing percent change from baseline in LDL-C for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin at varying doses. The vertical axis shows percent change, and the horizontal axis shows dose values (mg). Each statin has box plots illustrating variability and median changes at multiple dosages.*
FDA Label Image

Label (Lbl713352440)

Label (Lbl713352440)
Label for Rosuvastatin Tablets USP 5 mg oral film-coated tablets. The label shows the NDC number 71335-2440-1 and indicates the package contains 30 tablets. It is repackaged by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals, Inc. Storage and safety instructions are also included.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure of rosuvastatin calcium, showing the molecular arrangement including fluorophenyl group, sulfonamide, and carboxylate groups with calcium ions indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.